News About: Pharm. Industry
KPMA urged to come up with countermeasures over price-cut plan and KORUS FTA
The new executives of the Korea Pharmaceutical Manufacturers Association needs to assess the damage that the government’s impending price-cut plan and Korea’s free trade deals with the U.S. would cause in the pharmace...
Multinational firms eye price hike of OTC products
Multinational drug manufacturers are considering a price hike of their popular OTC brands in Korea in order to make up for their profit, industry sources said.
From March, the market price of Wyeth’s Centrum is exp...
Trast patch wooing customers
SK’s Chemicals’ anti-arthritis patch "Trast" is yielding sizable results in boosting its brand awareness.
In a survey of 300 people in their 40s to 60s in Seoul conducted by Hanseung Marketing, Trast gained over 50...
New COPD drug wins backing of US FDA panel advisers
The U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee (PADAC) on Feb. 24 voted 12 to 2 in favor of approving the New Drug Application (NDA) for Spain based Almirall’s aclidinium bromide, a...
Yoon Suk-geun, new head of Korea Pharmaceutical Manufacturers Association
The Korea Pharmaceutical Manufacturers Association, a leading pharmaceutical business lobby, said on February 23 it appointed Yoon Suk-geun, chairman of Ilsung Pharmaceutical Co., as its new head at the general meetin...
Prices of 100 drugs to be readjusted
The Health Insurance Review and Assessment Service said Thursday that the prices of 100 insurance-covered drugs will be increased upward.
The HIRA assesses the pricing opposition of 700 drugs from 92 pharmaceutical...
Government to push policy to slash drug prices
The Ministry of Health and Welfare expressed no change on its plan to slash the price of about half the drugs on the market by an average of 14 percent starting April.
In a compliment speech during the general meet...
Yuhan generous with dividends; Boryung least
Yuhan Corp. is likely to be the most generous and Boryung Pharmaceutical the least in offering cash dividend rewards among the leading 15 KOSPI-listed pharmaceutical firms in 2011, Yakup.com said yesterday.
Cash di...
Activists to hold rally to condemn Novartis’s suit in India
Korean activists from 16 civic groups resolved to hold a symbolic rally in front of Novartis Korea building in Seoul, to protest against Novartis’s attempts to weaken Indian Patent Law that threatens to restrict acces...
Pharmaceutical executive convicted
The Seoul Central District Court on Tuesday sentenced a 6-month jail term and 2-year suspension for a management official working at a pharmaceutical company on charges of giving 1.3 billion won to doctors for choosin...
